Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
4.290
-0.130 (-2.94%)
May 20, 2025, 9:50 AM - Market open

CDIO Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.020.030.0200-
Revenue Growth (YoY)
-39.68%104.45%1696.32%5.44%--
Gross Profit
0.020.030.0200-
Selling, General & Admin
5.788.357.14.490.570.6
Research & Development
0.020.030.150.040.030
Operating Expenses
5.868.47.264.550.620.61
Operating Income
-5.84-8.37-7.24-4.55-0.62-0.61
Interest Expense
-0.02-0.02-6.74---
Interest & Investment Income
000---
Other Non Operating Income (Expenses)
--5.41--0
EBT Excluding Unusual Items
-5.85-8.38-8.57-4.55-0.62-0.61
Merger & Restructuring Charges
----0.11--
Other Unusual Items
--0.19---
Pretax Income
-5.85-8.38-8.38-4.66-0.62-0.61
Net Income
-5.85-8.38-8.38-4.66-0.62-0.61
Net Income to Common
-5.85-8.38-8.38-4.66-0.62-0.61
Shares Outstanding (Basic)
110000
Shares Outstanding (Diluted)
110000
Shares Change (YoY)
120.13%112.00%310.83%165.44%12.35%-
EPS (Basic)
-5.13-9.35-19.81-45.29-16.00-17.53
EPS (Diluted)
-5.13-9.35-19.81-45.29-16.00-17.53
Free Cash Flow
-5.36-5.21-6.25-5.09-0.590.03
Free Cash Flow Per Share
-4.69-5.81-14.78-49.46-15.100.75
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-29335.69%-23977.87%-42440.43%-478784.32%-68862.15%-
Profit Margin
-29418.82%-24028.24%-49087.81%-490630.00%-68862.15%-
Free Cash Flow Margin
-26935.59%-14926.54%-36612.00%-535891.37%-64960.15%-
EBITDA
-5.47-8.09-7.13-4.53-0.6-0.6
D&A For EBITDA
0.370.280.110.020.020.01
EBIT
-5.84-8.37-7.24-4.55-0.62-0.61
Advertising Expenses
-0.180.160.090.10.01
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q